ATX-IN-3
Product Specifications
Target
PDE
Related Pathways
Metabolism
Bioactivity
ATX-IN-3 is an orally active autotaxin (ATX) inhibitor with an IC50 of 46 nM. It effectively ameliorates pulmonary fibrosis in mouse models by significantly reducing collagen deposition. ATX-IN-3 demonstrates excellent metabolic stability and drug-like properties, making it suitable for research on idiopathic pulmonary fibrosis (IFP) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![(S)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](https://cdn.genprice.uk/products/572/8114128659530/imageurl/trc-p318774-50mg.webp)
TRC-P318774-50MG 50 mg
(S)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
Sign In for Pricing
View Details 
BNC882005-500 1x 500 µL
CD40, Mouse (FGK45.5), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
AP50010PU-N 400 µL
Aminoadipate aminotransferase (AADAT) (Center) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details